MDMA-assisted therapy for PTSD in young adults with childhood trauma
Part of Mental health clinical trials.
This study tests whether MDMA combined with talk therapy can help young adults who have PTSD from childhood trauma. It involves several therapy sessions where you take MDMA in a clinical setting to help process the trauma.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 26 years old and live in the United States.
- You must be able to speak and read English and give your informed consent.
- You must have PTSD that started from a trauma you experienced in childhood.
- You cannot take psychiatric medications during the study, and you must be willing to stop if you are currently taking them.
- You must have someone you trust who can stay overnight with you after each therapy session and drive you home.
- You must be willing to avoid alcohol and cannabis for one week before and after each session, and be free of other substance use disorders.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether high-dose MDMA, given during intensive inpatient therapy, can help people with PTSD that hasn't improved with other treatments. It takes place at a specialized trauma center and involves several therapy sessions with the drug.
This study tests whether MDMA-assisted therapy can help veterans who have both PTSD and alcohol use disorder. If you have tried a standard therapy before and want to reduce or stop drinking, this treatment may offer a new option.
This Phase 2 study tests whether MDMA combined with therapy that uses exposure (gradual confronting of trauma memories) can reduce PTSD symptoms. It may help people who meet PTSD criteria, can follow strict safety rules, and can complete medicine-session monitoring.
This study tests whether MDMA, combined with a type of talk therapy called CBCT (cognitive behavioral conjoint therapy), is more effective than CBCT alone for treating PTSD. You and a close partner will both participate in therapy sessions and take MDMA together.
This study tests whether MDMA (a drug that can help people feel safe and open during therapy) combined with talk therapy can reduce PTSD symptoms in active-duty service members, National Guard, and Reserve members. If you are struggling with PTSD that has lasted at least 6 months, this trial may offer a new treatment option.
This study tests whether MDMA (a medication) combined with therapy can help veterans with post-traumatic stress disorder (PTSD). MDMA may help people process difficult memories and emotions more effectively during therapy sessions.
Hear when a new Posttraumatic Stress Disorder (PTSD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.